PTPRG and chronic myelogenous leukemia, BCR-ABL1 positive: These results fully confirm and extend to primary cells the previous data that indicate an active role of this phosphatase in BCR-ABL1 activation and β-catenin degradation and, consequently, the inverse correlation between PTPRG expression and BCR-ABL1 activity in cells isolated by the peripheral blood of CML patients.